Skip to main content

IPH · INNATE PHARMA · Financials

1.3200 EUR +0.0040 (+0.30%) At close · Oct 5
Market Cap
157.94M EUR
Shares
111.70M

Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.

Browse captured authority reports and their original financial labels

Revenue
20.12M -67.4%
FY2024 Revenue FY2019–FY2024
Net Income
-49.47M -553.5%
FY2024 Net Income FY2019–FY2024
Operating Margin
-256.32% -235.8pp
FY2024 Operating Margin FY2019–FY2024
Operating Cash Flow
-6.9M +78.8%
FY2024 Operating Cash Flow FY2019–FY2024

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item FY2024 FY2023 FY2022 FY2021 FY2020 FY2019
EUR 20.12M 61.64M 57.67M 24.7M 69.77M 85.81M
EUR 51.98M 56.02M 51.66M 47M 49.71M 78.84M
EUR -51.58M -12.67M -57.43M -47.83M 1.08M -27.05M
EUR 3.98M 1.84M 5.32M 4M 6.76M 4.98M
EUR -49.47M -7.57M -57.97M -45.48M -829K -20.76M
EUR 0 0 0 0 0 0
EUR -49.47M -7.57M -58.1M -52.81M -63.98M -20.76M
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

Covenants

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

Loans, facilities and notes

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.